InflaRx to Participate in Upcoming Investor Conferences
Provided By GlobeNewswire
Last update: May 22, 2025
JENA, Germany, May 22, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced that the Company will participate in multiple investor conferences in June and July 2025.
Read more at globenewswire.com
